4D Advisors LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

4D Advisors LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 15,000 shares of the biotechnology company's stock, valued at approximately $8,915,000. Axon Enterprise makes up 6.2% of 4D Advisors LLC's holdings, making the stock its 2nd biggest holding.

A number of other large investors have also added to or reduced their stakes in the company. Wilmington Savings Fund Society FSB purchased a new stake in Axon Enterprise during the third quarter valued at approximately $759,000. Tidal Investments LLC raised its holdings in Axon Enterprise by 13.8% during the 3rd quarter. Tidal Investments LLC now owns 3,250 shares of the biotechnology company's stock valued at $1,299,000 after buying an additional 394 shares during the period. Oddo BHF Asset Management Sas bought a new stake in Axon Enterprise in the third quarter worth $1,522,000. Principal Financial Group Inc. boosted its stake in Axon Enterprise by 33.1% during the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company's stock worth $54,466,000 after buying an additional 33,869 shares during the period. Finally, Versant Capital Management Inc raised its stake in shares of Axon Enterprise by 4,750.0% in the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock valued at $58,000 after acquiring an additional 95 shares during the period. Institutional investors own 79.08% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Needham & Company LLC reaffirmed a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, April 23rd. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 target price on the stock. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $626.45.

Axon Enterprise Stock Up 0.2 %

NASDAQ AXON traded up $0.94 during midday trading on Wednesday, hitting $602.61. 253,394 shares of the company traded hands, compared to its average volume of 747,621. The company has a market cap of $46.91 billion, a PE ratio of 155.71, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company's 50-day simple moving average is $556.70 and its 200-day simple moving average is $580.42.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.